IMGN779 is an anti CD33 antibody linked to an alkylating drug (indolinobenzodiazepine-pseudodimer IGN) with potent anti AML activity in vitro, mostly in the presence of FLT3-ITD [113]. This evidence concerns the gene CD33 and acute myeloid leukemia.